Kiora Pharmaceuticals INC (KPRX) — 10-K Filings
All 10-K filings from Kiora Pharmaceuticals INC. Browse 1 Annual Report reports with AI-powered summaries and risk analysis.
10-K Filings (1)
-
Kiora Advances Retinal Disease Pipeline with Two Phase 2 Trials Underway
— Mar 25, 2026 Risk: high
KIORA PHARMACEUTICALS INC (KPRX) is a clinical-stage specialty pharmaceutical company focused on retinal diseases. For the fiscal year ended December 31, 2025,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX